Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Tables)

v3.26.1
Stockholders' Equity (Tables)
3 Months Ended
Mar. 31, 2026
Stockholders' Equity  
Schedule of Stock-Based Compensation Expense

Three Months Ended March 31, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Fortress:

Employee and non-employee awards

$

543

$

2,607

Executive awards

 

133

 

180

Partner Companies:

Avenue

 

61

 

185

Checkpoint

 

 

1,956

Mustang

 

22

 

38

Journey

989

1,323

Other

 

8

 

Total stock-based compensation expense

$

1,756

$

6,289

Three Months Ended March 31, 

($ in thousands)

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

$

23

$

1,342

Selling, general and administrative

 

1,733

 

4,946

Total stock-based compensation expense

$

1,756

$

6,289

Schedule of Restricted Stock Awards and Restricted Stock Units

  ​ ​ ​

  ​ ​ ​

Weighted

average grant

Number of shares

price

Unvested balance at December 31, 2025

3,841,748

$

3.62

Restricted stock granted

1,087,458

3.22

Restricted stock vested

(37,037)

17.55

Restricted stock units vested

(129,409)

22.45

Unvested balance at March 31, 2026

4,762,760

$

2.91

Schedule of Warrant activities

Total weighted

Weighted average

average

remaining

Number of

Weighted average

 intrinsic

contractual life

  ​ ​ ​

shares

  ​ ​ ​

exercise price

  ​ ​ ​

value

  ​ ​ ​

(years)

Outstanding as of December 31, 2025

 

13,431,502

$

2.21

$

 

3.55

Exercised

(694,296)

1.74

Outstanding as of March 31, 2026

 

12,737,206

$

2.24

$

9,227,711

 

3.30